Drug policy reform advocates pen letter-to-the-editor to Journal of the American Medical Association (JAMA) encouraging them to not confuse specific cannabinoid research with whole cannabis products in general as an effective and safe medicinal therapeutic.
Some questions are directly about marijuana and some are more general beliefs and opinions. the survey also takes a close look at drug and alcohol use, some symptoms of anxiety and depression, and personality characteristics.
It’s markedly shorter than surveys in the past NORML’s highlighted and should intrigue most folks in the NORML community.
Of course, in an effort to get to the bottom of the so-called “potent pot” story, Ms. Yen might have thought to inquire why the US National Drug Intelligence Center’s 2007 National Drug Threat Assessment states